SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Veracyte Inc. (VCYT) on Tuesday reported a loss of $1.9 million in its first quarter.
The South San Francisco, California-based company said it had a loss of 2 cents per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.
The molecular diagnostic company posted revenue of $96.8 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $93.8 million.